IFAM
AGIO icon

Institutional & Family Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Institutional & Family Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10
Closed – – 861
2020
Q3 		$0 Hold
10
– – ﹤0.01% 828
2020
Q2 		$1K Hold
10
– – ﹤0.01% 747
2020
Q1 		$0 Hold
10
– – ﹤0.01% 808
2019
Q4 		$0 Hold
10
– – ﹤0.01% 850
2019
Q3 		$0 Hold
10
– – ﹤0.01% 832
2019
Q2 		$0 Hold
10
– – ﹤0.01% 841
2019
Q1 		$1K Hold
10
– – ﹤0.01% 767
2018
Q4 		$0 Buy
+10
New +$617 ﹤0.01% 820

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Institutional & Family Asset Management's AGIO Position: Q4 2020 in Review

Institutional & Family Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 10 shares.

Institutional & Family Asset Management first reported a position in AGIO in Q4 2018 and held it in 8 quarters. The position peaked at $1K in Q2 2020. 200 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Institutional & Family Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 10 Agios Pharmaceuticals shares in Q4 2020.
  • Institutional & Family Asset Management first reported a position in Agios Pharmaceuticals in Q4 2018 and held it in 8 quarters.
  • Institutional & Family Asset Management's Agios Pharmaceuticals position peaked at $1K in Q2 2020.
  • 200 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Institutional & Family Asset Management's 13F filing for Q4 2020, filed 3 Feb 2021.